92 related articles for article (PubMed ID: 11520095)
1. New drugs and combinations in the palliative treatment of colon and rectal cancer.
Beretta GD; Pessi MA; Poletti P; Mosconi S; Labianca R
Eur J Surg Oncol; 2001 Sep; 27(6):595-600. PubMed ID: 11520095
[TBL] [Abstract][Full Text] [Related]
2. Capecitabine and tegafur + uracil: new preparations. Metastatic colorectal cancer: two oral fluorouracil precursors, few advantages.
Prescrire Int; 2002 Apr; 11(58):44-7. PubMed ID: 11987311
[TBL] [Abstract][Full Text] [Related]
3. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy in metastatic colorectal cancer.
Christopoulou A
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s43-6. PubMed ID: 15655639
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival.
Hotta T; Takifuji K; Arii K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H
Anticancer Res; 2006; 26(2B):1425-32. PubMed ID: 16619554
[TBL] [Abstract][Full Text] [Related]
6. Deleted in colon cancer protein expression in colorectal cancer metastases: a major predictor of survival in patients with unresectable metastatic disease receiving palliative fluorouracil-based chemotherapy.
Aschele C; Debernardis D; Lonardi S; Bandelloni R; Casazza S; Monfardini S; Gallo L
J Clin Oncol; 2004 Sep; 22(18):3758-65. PubMed ID: 15365072
[TBL] [Abstract][Full Text] [Related]
7. The role of uracil-tegafur (UFT) in elderly patients with colorectal cancer.
Labianca R; Beretta GD; Mosconi S; Milesi L
Crit Rev Oncol Hematol; 2004 Oct; 52(1):73-80. PubMed ID: 15363468
[TBL] [Abstract][Full Text] [Related]
8. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
Surgery; 2007 Nov; 142(5):741-8. PubMed ID: 17981195
[TBL] [Abstract][Full Text] [Related]
9. Human colorectal malignancy and oral UFT.
Sakamoto S; Tsukada K; Sagara T; Kawachi Y; Murakami S; Iwama T
Anticancer Res; 2002; 22(1A):339-41. PubMed ID: 12017314
[TBL] [Abstract][Full Text] [Related]
10. [Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
Ishida H; Yamada H; Shirakawa K; Nakada H; Ohsawa T; Takeuchi I; Okada N; Yokoyama M; Inokuma S; Suzuki T; Odaka A; Hoshino T; Murata N; Hashimoto D; Itoyama S; Mori T; Matsumoto Y; Miura T
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1621-6. PubMed ID: 14619479
[TBL] [Abstract][Full Text] [Related]
11. Quality of life versus prolongation of life in patients treated with chemotherapy in advanced colorectal cancer: A review of randomized controlled clinical trials.
de Kort SJ; Willemse PH; Habraken JM; de Haes HC; Willems DL; Richel DJ
Eur J Cancer; 2006 May; 42(7):835-45. PubMed ID: 16481158
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of ambulatory patient cancer chemotherapy for advanced colorectal cancer].
Toyokawa A; Tsujimura T; Hamabe Y; Sato S; Mukubou H; Wakahara T; Kaji M; Tsukamoto T; Wakita K; Onishi N; Ishida T; Watanabe A; Fujiwara H; Mukai H
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2087-90. PubMed ID: 16352933
[TBL] [Abstract][Full Text] [Related]
13. UFT as maintenance therapy in patients with advanced colorectal cancer responsive to the FOLFOX4 regimen.
Scalamogna R; Brugnatelli S; Tinelli C; Sagrada P; Gattoni E; Tronconi MC; Riccardi A; Luchena G; Corazza GR
Oncology; 2007; 72(5-6):267-73. PubMed ID: 18187947
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary treatment of colorectal cancer in New Zealand: survival rates from 1997-2002.
Keating J; Yong D; Cutler G; Johnston J
N Z Med J; 2006 Sep; 119(1242):U2238. PubMed ID: 16998579
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
Okita NT; Yamada Y; Takahari D; Hirashima Y; Matsubara J; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
Jpn J Clin Oncol; 2009 Sep; 39(9):595-600. PubMed ID: 19535387
[TBL] [Abstract][Full Text] [Related]
17. Optimal treatment of metastatic colorectal cancer.
Pessino A; Sobrero A
Expert Rev Anticancer Ther; 2006 May; 6(5):801-12. PubMed ID: 16759170
[TBL] [Abstract][Full Text] [Related]
18. Indication and efficacy of adjuvant chemotherapy with oral fluoropyrimidines for dukes' B colorectal cancer.
Yoshimatsu K; Umehara A; Ishibashi K; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Anticancer Res; 2006; 26(4B):3089-93. PubMed ID: 16886639
[TBL] [Abstract][Full Text] [Related]
19. Perspectives in the treatment of colorectal cancer.
Ozer H; Diasio RB
Semin Oncol; 2004 Dec; 31(6 Suppl 15):14-8. PubMed ID: 15726534
[TBL] [Abstract][Full Text] [Related]
20. [Combined chemotherapy with oral leucovorin (LV) + tegafur/uracil (UFT) and hepatic arterial infusion (HAI) therapy for liver metastasis of colorectal cancer].
Hasegawa S; Matsumoto S; Kawashima K; Fujii H; Hatano E; Satoh S; Ikai I; Shimahara Y
Gan To Kagaku Ryoho; 2005 Jul; 32(7):1045-9. PubMed ID: 16044971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
